According to IVERIC bio's latest financial reports the company's current EPS (TTM) is -$1.76. In 2022 the company made an earnings per share (EPS) of -$1.52 a decrease over its 2021 EPS that were of -$1.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.76 | 15.79% |
2022 | -$1.52 | 34.51% |
2021 | -$1.13 | -0.88% |
2020 | -$1.14 | -17.99% |
2019 | -$1.39 | -193.92% |
2018 | $1.48 | -53.46% |
2017 | $3.18 | -158.35% |
2016 | -$5.45 | 78.69% |
2015 | -$3.05 | -15.98% |
2014 | -$3.63 | -84.43% |
2013 | -$23.31 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 23.86% | ๐บ๐ธ USA |